UNLIMITED TURBO BULL - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Euronext Paris 12:30:00 2024-07-11 pm EDT | ||
| 1.085 EUR | +6.90% |
|
| Current month | +17.30% | ||
| 1 month | +17.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
Latest news about RECORDATI
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 1.085 | +6.90% |
| 24-07-10 | 1.015 | +10.93% |
| 24-07-09 | 0.915 | -3.17% |
| 24-07-08 | 0.945 | -2.07% |
| 24-07-05 | 0.965 | 0.00% |
Real-time Euronext Paris
Last update July 11, 2024 at 12:30 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | 
Société Générale
|
| 5G71S | |
| ISIN | DE000SW8YDG5 |
| Date issued | 2024-04-12 |
| Strike | 39.52 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.97 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.395 € |
|---|---|
| Lowest since issue | 0.815 € |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
50.25
EUR
Average target price
52.64
EUR
Spread / Average Target
+4.76%
- Stock Market
- Certificates
- 5G71S Certificat
